MATTHEW SWIATOWICZ: Open Payments
NPI 1801150594 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,870 in 92 payments from 22 companies in 2025. Trend: 2023 $2,326 · 2024 $2,333 · 2025 $1,870
Food & beverage: $1,870
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 17 | $411 |
| Abbott Laboratories | 9 | $196 |
| Novo Nordisk Inc | 11 | $196 |
| Dexcom, Inc. | 12 | $195 |
| SANOFI-AVENTIS U.S. LLC | 7 | $175 |
| Amgen Inc. | 9 | $159 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| Radius Health, Inc. | 2 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $54 |
| Lilly USA, LLC | 3 | $52 |
Products named: Omnipod, FREESTYLE LIBRE 3, Dexcom G6 Transmitter, TZIELD, Rybelsus, EVENITY, JARDIANCE, GVOKE HYPOPEN.
Industry payments across FL — which companies pay providers there.
